Ferring Pharmaceuticals

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. They are a leader in reproductive medicine and maternal health, and also focus on specialty areas within gastroenterology and urology, with over 50 years of experience in developing treatments for mothers and babies.

Products & Services

Reproductive Medicine & Maternal Health:Innovative treatments focused on fertility, safe birth, and preterm birth to support mothers and babies from conception to birth.

Gastroenterology & Microbiome:Solutions targeting inflammatory bowel diseases and Clostridioides difficile infection, including microbiome research.

Urology & Uro-Oncology:Treatments for bladder cancer, prostate cancer, bedwetting, and nocturia.

Endocrinology:Products addressing endocrine disorders.

Orthopaedics:Solutions for orthopaedic health.

Gene Therapy (e.g., Adstiladrin - nadofaragene firadenovec):Non-replicating gene therapy for non-muscle invasive bladder cancer.

Specialties

Reproductive Medicine Maternal Health Gastroenterology Urology Uro-Oncology Microbiome Research Gene Therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 80000000 MR: - FA: CHF 80 million FAN: 80000000	D: 2023-06-16 FD: 2023-06-16	-

Debt Latest

2023-06-16

$80.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Frederik Paulsen

Chairman Emeritus of the Ferring Group

E

Eva Paulsen

Founder

E

Eunice Lopez

J

Jaime Sued

E

Eduardo Mendoza

S

Samir Eldemiry

View 20 more team members with Pro

Unlock Full Team Directory

Recent News